Cassava Sciences | PTIE - Ebit

Aktienkurs
1.87
Täglich Wechseln
0.08 4.47%
Monatlich
-13.43%
Jährlich
-34.15%
Q1 Prognose
1.74




Ebit Veränderung Datum
Abbott USD 2.54B 358M 2025-12
Amgen USD 3.96B 464M 2025-12
Biogen USD 659.6M 157M 2025-09
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cassava Sciences USD -13.55M 1.69M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Geron USD -10.79M 3.1M 2025-12
J&J USD 5.11B 2.3B 2025-12
Merck USD 6.24B 1.32B 2025-12
Novartis USD 4.06B 530M 2025-12
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.65B 71M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12